Treatment of metastatic renal cell carcinoma in the Czech Republic according to RENIS database

Abstract

Therapy of metastatic renal cell carcinoma (mRCC) with targeted inhibitors of key cellular processes is a relative new option for systemic treatment. Its optimum use requires, among others, a thorough analysis of the results obtained in routine clinical practice.

These data for the Czech Republic are collected in the RENIS database.

Keywords

• approach
• targeted
• therapy
• patients
• metastatic
• renal
• carcinoma
• progression
• treatment
• pazopanib